BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Phase III Study Results Showed Eisai Company, Ltd.'s Eribulin Mesylate Significantly Improved Overall Survival in Patients with Locally Recurrent or Metastatic Breast Cancer

  June 7, 2010

   · 

  7 min read
• Drug Development

  Successful Phase III Clinical Trial Results Reported for NovoCure Ltd.'s Novel Medical Device for Treatment of Recurrent Glioblastoma

  June 7, 2010

   · 

  4 min read
• Drug Development

  Delcath Systems, Inc. Highlights Phase III Trial Results Presented at American Society of Clinical Oncology

  June 7, 2010

   · 

  3 min read
• Drug Development

  Data From Clinical Studies of bioTheranostics CancerTYPE ID(R) and Breast Cancer Index(R) Molecular Oncology Tests Presented at American Society of Clinical Oncology 2010 Annual Meeting

  June 7, 2010

   · 

  4 min read
• Biotech Bay

  IMPAX Laboratories, Inc. to Present at Upcoming Investor Conferences on June 10

  June 7, 2010

   · 

  1 min read
• BioMidwest

  New Mexico Biotechnology and Biomedical Associatio President Dr. Shannon Sheehan Promotes State’s Bioscience Industry in Washington D.C.

  June 7, 2010

   · 

  1 min read
• Drug Development

  MethylGene Presents Encouraging Clinical and Preclinical Data for MGCD265 at the American Society of Clinical Oncology 2010 Annual Meeting

  June 7, 2010

   · 

  12 min read
• BioMidwest

  Genomic Health, Inc. Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology Annual Meeting

  June 7, 2010

   · 

  12 min read
• Drug Development

  Eyetech Inc. Release: Phase 3 Study Presented at World Ophthalmology Congress Evaluates Investigational Use of Macugen in Patients With Diabetic Macular Edema

  June 7, 2010

   · 

  8 min read
• Drug Development

  Alder Biopharmaceuticals Inc.'s ALD518 Antibody Therapeutic Reduces Disease Symptoms, Anemia in Phase 2a Clinical Trial in Non-Small Cell Lung Cancer Patients

  June 7, 2010

   · 

  3 min read